Navigation Links
RNase Inhibitor (Cloned) from Ambion

ProductsRNase Inhibitor (Cloned) from Ambion
Company Ambion
Item RNase Inhibitor (Cloned)
Price $94.00
Description Ambion's RNase Inhibitor is a recombinant human protein produced in E. coli and is a potent inhibitor of neutral pancreatic RNase A type enzymes. The mode of inhibition is noncompetitive; the inhibitor tightly binds RNases in a 1:1 ratio. The enzyme has been shown to inactivate RNases present in many tissues and cell types. Addition of the ribonuclease inhibitor has been shown to be useful whenever the integrity of RNA must be maintained such as in the preparation of cDNA by reverse transcription, in vitro RNA transcription and in in vitro protein synthesis, and RNA isolation and preparation of RNase-free antibodies. Ribonuclease inhibitor does not inhibit RNase 1, T1, T2, H, U1, U2 or CL3. Ribonuclease inhibitor requires a minimum of 1 mM DTT to maintain activity, and has an activity range between pH 5.0 to 8.0 with maximal activity between pH 7.0 and 8.0.
Info AmbionAmbion
2130 Woodward
Austin, TX 78744
USA

Call Ambion to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-512-795-4221
Customer Service: 512-651-0200
Fax Number: 512-651-0201
Web Site: http://www.ambion.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. DNase I (RNase-free) (2 U/l) from Ambion
2. QIAGEN RNase Inhibitor (7500 U) from QIAGEN
3. ShortCut RNase III from New England Biolabs
4. RNase H from Roche Applied Science
5. RNase-Free Dnase from BD Biosciences Pharmingen
6. RQ1 RNase-Free DNase from Promega
7. DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
8. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
9. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
10. RNase Inhibitor from Applied Biosystems
11. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
Stand for Multichannel Pipettes from Thermo Scientific
...lynucleotide Kinase (PNK) catalyzes the transfer o...of single- and double-stranded DNA, RNA, and nucle...he 3'-phosphate from 3'-phosphoryl polynucleotides...ribonucleoside 3', 5'-diphosphates to form a 3'-hy...
T3 RNA Polymerase from Roche Applied Science
Maxi 14 Hybridization Oven from Thermo Scientific
Biology Products:
(Date:11/26/2009)...st worked out a way of using recordings of birdson...ns. This is the first time sound recordings from a...te estimates of bird species, populations. Because...ical Society,s Journal of Applied Ecology , will ...r advance in our ability to monitor whale and dolp...
(Date:11/26/2009)...istant Staphylococcus Aureus ) and other drug-res...perature plasma prototype devices have been develo...ricidal cocktails. , Two prototype devices have ...healthy skin (e.g. hands and feet) in hospitals an...hreat; and another to shoot bacteria-killing agent...
(Date:11/25/2009)...fighters, police officers and ambulance workers fa...Center complex. They battled to save people from t... tackled fires and evacuated as many people as the...,000 people. And making their jobs even harder was...rkers and their relatives jammed mobile networks w...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3NutraCea Announces Additions to Management Team 3B Chief Operating Officer Extends Employment Contract 53478 1NutraCea Announces Additions to Management Team 3B Chief Operating Officer Extends Employment Contract 53478 2NutraCea Announces Additions to Management Team 3B Chief Operating Officer Extends Employment Contract 53478 3NutraCea Announces Additions to Management Team 3B Chief Operating Officer Extends Employment Contract 53478 4St Joseph Health System Sonoma County Partners With Aegis Health Group to Bring Health Management Program to Area Employers 53473 1St Joseph Health System Sonoma County Partners With Aegis Health Group to Bring Health Management Program to Area Employers 53473 2AEterna Zentaris Partner Keryx Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine 28KRX 0401 29 for th 13324 1AEterna Zentaris Partner Keryx Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine 28KRX 0401 29 for th 13324 2AEterna Zentaris Partner Keryx Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine 28KRX 0401 29 for th 13324 3AEterna Zentaris Partner Keryx Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine 28KRX 0401 29 for th 13324 4
... researchers have successfully induced differentia...o behave like embryonic stem cells. The researcher...blication of the journal Cell. , The cells--which...em cells" (iPS)--exhibit the physical, growth, and... cells, they reported. "Pluripotent" refers to the...
...oteins created by the cystic fibrosis gene has bee...apel Hill scientists. Turning off the degradation ... shape, offering a new avenue for treatments aimed...is a fatal disease caused by a defective gene that...ibrosis transmembrane conductance regulator (CFTR)...
...mental RNA-based drug -- the first of its kind -- ... springs into action to destroy them, while leavin...Duke University Medical Center, uses one type of g...ncer cells, and another type, called silencing RNA...he cells alive. , In tests in mice with prostate...
Other Biology News:With few factors, adult cells take on character of embryonic stem cells 2Study reveals how cells destroy faulty proteins in cystic fibrosis 2Experimental RNA-based drug kills prostate cancer cells effectively and safely 2
(Date:11/25/2009)... , ,, BOCA RATON, Fla., ...has been a painful year. Not so for BodyLogicMD. ...f expert physicians specializing exclusively in me...own the number of physicians in its network ...and is in progress to add more physician-owned cen...
(Date:11/25/2009)... , SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ -...ed today that Barry D. Quart, Pharm.D., president ...iper Jaffray 21st Annual Health Care Conference. ,...fray 21st Annual Health Care Conference,Date: ...stern Time,Location: The New York Palace Hotel, N...
(Date:11/24/2009)... The New York investment bank K...X:NEU) has agreed an AU$6.7 mil convertible note p...r. The private placement was arranged by KTA Capit...or. , New York (PRWEB) No...ment bank KTA Capital, LLC ("KTA Capital"...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCall/...l be presenting at the NASDAQ OMX conference on Tu... AM US/CST. Interested parties may listen via live...http://inve s tor.sig m a a ldrich.com/ . ...file. ,, About Sigma-Aldrich: Sigma-Aldri...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2